-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
- Beam Therapeutics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$105M, a 2.69% decline year-over-year.
- Beam Therapeutics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$184M, a 51.6% increase year-over-year.
- Beam Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$176M, a 47.9% increase from 2022.
- Beam Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$338M, a 13.8% increase from 2021.
- Beam Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$392M, a 196% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)